Stay updated on GB002 Open-Label Extension in PAH Clinical Trial
Sign up to get notified when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.

Latest updates to the GB002 Open-Label Extension in PAH Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check9 days agoChange DetectedA sitewide NIH announcement about terminology changes during a federal transition was removed from the page; the 403 error content remains.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check30 days agoChange DetectedA site-wide NIH notice explains that agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check44 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the record content. This indicates a permissions issue rather than an update to the study information.SummaryDifference17%

Stay in the know with updates to GB002 Open-Label Extension in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.